Sei Investments Co. Trims Stock Position in Danaher Co. (NYSE:DHR)

Sei Investments Co. lessened its stake in shares of Danaher Co. (NYSE:DHR - Free Report) by 2.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,017,357 shares of the conglomerate's stock after selling 24,243 shares during the quarter. Sei Investments Co. owned about 0.14% of Danaher worth $233,541,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in DHR. Geo Capital Gestora de Recursos Ltd lifted its holdings in shares of Danaher by 5,626.7% during the 4th quarter. Geo Capital Gestora de Recursos Ltd now owns 4,295 shares of the conglomerate's stock valued at $986,000 after buying an additional 4,220 shares during the period. Plancorp LLC lifted its stake in shares of Danaher by 9.0% in the 4th quarter. Plancorp LLC now owns 4,046 shares of the conglomerate's stock worth $929,000 after purchasing an additional 335 shares during the period. Mizuho Securities USA LLC boosted its holdings in shares of Danaher by 46.2% in the fourth quarter. Mizuho Securities USA LLC now owns 60,925 shares of the conglomerate's stock worth $13,985,000 after buying an additional 19,245 shares during the last quarter. Quantbot Technologies LP purchased a new position in shares of Danaher in the fourth quarter worth approximately $2,849,000. Finally, Millstone Evans Group LLC bought a new stake in Danaher during the fourth quarter valued at approximately $101,000. 79.05% of the stock is currently owned by institutional investors.

Danaher Trading Down 1.1 %

Shares of NYSE:DHR traded down $2.25 during trading on Wednesday, hitting $210.15. The company had a trading volume of 2,669,221 shares, compared to its average volume of 3,016,049. The stock has a market cap of $150.19 billion, a price-to-earnings ratio of 39.80, a price-to-earnings-growth ratio of 2.66 and a beta of 0.82. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. The company has a fifty day simple moving average of $216.41 and a two-hundred day simple moving average of $237.75. Danaher Co. has a one year low of $196.80 and a one year high of $281.70.

Remove Ads

Danaher (NYSE:DHR - Get Free Report) last announced its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, meeting the consensus estimate of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same period in the prior year, the company earned $2.09 EPS. As a group, equities analysts forecast that Danaher Co. will post 7.63 earnings per share for the current year.

Danaher Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be given a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a dividend yield of 0.61%. The ex-dividend date is Friday, March 28th. This is a positive change from Danaher's previous quarterly dividend of $0.27. Danaher's payout ratio is 24.24%.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on the stock. The Goldman Sachs Group raised shares of Danaher from a "neutral" rating to a "buy" rating and set a $260.00 price objective for the company in a research report on Friday, March 21st. Raymond James reaffirmed a "market perform" rating on shares of Danaher in a research note on Monday, February 3rd. Jefferies Financial Group cut their price objective on Danaher from $285.00 to $260.00 and set a "buy" rating for the company in a research note on Wednesday, January 29th. Scotiabank assumed coverage on shares of Danaher in a research report on Monday, December 23rd. They issued a "sector perform" rating and a $265.00 price target for the company. Finally, Guggenheim initiated coverage on shares of Danaher in a research report on Thursday, December 19th. They set a "buy" rating and a $275.00 price objective on the stock. Five analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company's stock. According to data from MarketBeat, Danaher presently has an average rating of "Moderate Buy" and a consensus price target of $278.24.

Insider Transactions at Danaher

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the company's stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the transaction, the senior vice president now owns 20,230 shares of the company's stock, valued at $4,534,149.90. This represents a 21.98 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Company insiders own 11.10% of the company's stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.